Back
CytomX Therapeutics Stock Price Chart

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now
Sell
37
CTMX
CytomX Therapeutics
Last Price:
$2.45
Seasonality Move:
-7.02%
7 Day Trial
ALL ACCESS PASS
$
7

One Tool. Personalized Setups.
Try it here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTMX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CytomX Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.27 | Buy |
20-day SMA: | 2.44 | Buy |
50-day SMA: | 1.94 | Buy |
200-day SMA: | 1.18 | Buy |
8-day EMA: | 2.34 | Buy |
20-day EMA: | 2.33 | Buy |
50-day EMA: | 1.95 | Buy |
200-day EMA: | 0.86 | Buy |
CytomX Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 56.59 | Buy |
Chaikin Money Flow: | 553282 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.25 - 2.69) | Buy |
Bollinger Bands (100): | (0.48 - 2.12) | Buy |
CytomX Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for CytomX Therapeutics Stock
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 2.48 while CTMX 8-day simple moving average is 2.27, which is a Buy signal.
-
The stock price of CTMX is 2.48 while CytomX Therapeutics 20-day SMA is 2.44, which makes it a Buy.
-
CytomX Therapeutics 50-day simple moving average is 1.94 while CTMX share price is 2.48, making it a Buy technically.
-
CTMX stock price is 2.48 and CytomX Therapeutics 200-day simple moving average is 1.18, creating a Buy signal.
CTMX Technical Analysis vs Fundamental Analysis
Sell
37
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy or a Sell?
-
CytomX Therapeutics stock is rated a SellThe current CytomX Therapeutics [CTMX] share price is $2.48. The Score for CTMX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
CytomX Therapeutics Stock Info
Market Cap:
390.7M
Price in USD:
2.48
Share Volume:
783.8K
CytomX Therapeutics 52-Week Range
52-Week High:
3.10
52-Week Low:
0.40
Sell
37
CytomX Therapeutics (CTMX)
is a Sell
CytomX Therapeutics Share Price Forecast
-
What is the CytomX Therapeutics stock price today?The CytomX Therapeutics stock price is 2.48 USD today.
-
Will CTMX stock go up or go down?CytomX Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is CytomX Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics is overvalued.
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 2.48 while CTMX 8-day exponential moving average is 2.34, which is a Buy signal.
-
The stock price of CTMX is 2.48 while CytomX Therapeutics 20-day EMA is 2.33, which makes it a Buy.
-
CytomX Therapeutics 50-day exponential moving average is 1.95 while CTMX share price is 2.48, making it a Buy technically.
-
CTMX stock price is 2.48 and CytomX Therapeutics 200-day simple moving average is 0.86, creating a Buy signal.
Fundamental Analysis of CytomX Therapeutics
Is CytomX Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.32 per share.
Technical Analysis of CytomX Therapeutics
Should I short CytomX Therapeutics stock?
-
CTMX Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting CytomX Therapeutics is a Buy
-
CytomX Therapeutics Relative Strength Index (RSI) is 56.59, which suggest CytomX Therapeutics is overbought
-
The Bollinger Bands (25) for CytomX Therapeutics is (2.25 - 2.69), which suggest CytomX Therapeutics is a Buy
-
The Bollinger Bands (100) for CytomX Therapeutics is (0.48 - 2.12), which suggest CytomX Therapeutics is a Buy
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.